CN Patent

CN1856469A — 用于治疗和预防疾病和疾病症状的氟代ω－羧芳基二苯基脲

Assigned to Bayer Healthcare LLC · Expires 2006-11-01 · 20y expired

What this patent protects

式(I)的化合物：(I)其盐、其前药、其代谢物、含有这种化合物的药物组合物，以及这种化合物和组合物在治疗由raf、VEGFR、PDGFR、p38和flt－3介导的疾病中的应用。

USPTO Abstract

式(I)的化合物：(I)其盐、其前药、其代谢物、含有这种化合物的药物组合物，以及这种化合物和组合物在治疗由raf、VEGFR、PDGFR、p38和flt－3介导的疾病中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN1856469A
Jurisdiction
CN
Classification
—
Expires
2006-11-01
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Healthcare LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.